Skip to main content
Clinical Trials/IRCT20201128049520N1
IRCT20201128049520N1
Not yet recruiting
Phase 2

The effect of alcoholic extract of the olive leaf on clinical and Laboratory outcomes of patients with Covid-19

Khoram-Abad University of Medical Sciences0 sites129 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Khoram-Abad University of Medical Sciences
Enrollment
129

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 70 years (—)
Sex
All

Inclusion Criteria

  • All patients with Quid\-19 based on standard diagnostic test (positive PCR test, CT scan of lung) approved by infectious disease specialist
  • Age range is 18 to 70 years
  • Have a level of consciousness of 15 according to the Glasgow standard

Exclusion Criteria

  • Take oleopurine supplements 3 months before the study
  • Use of mechanical ventilation equipment
  • Existence of underlying respiratory diseases such as COPD, asthma
  • Taking anti\-hypertensive, anti\-platelet and anti\-diabetic drugs
  • Pregnancy and lactation
  • Immune system deficiency or the use of immunosuppressive drugs
  • Malignancies
  • Presence of heart, kidney, liver, blood pressure, diabetes and corticosteroid disorders
  • Reluctance to continue cooperation
  • The patient is discharged earlier than the completion of the treatment period

Investigators

Sponsor
Khoram-Abad University of Medical Sciences

Similar Trials